Christoph Eberle

Christoph Eberle, PhD, MICR, FRSPH

Principal Scientist III, Pharmacology

Christoph Eberle currently works as a principal scientist III at Charles River's Worcester facility in Massachusetts, where he expanded flow cytometry capabilities of the in vivo pharmacology/oncology team. In his role, he oversees immunophenotyping of tissue samples collected from various mouse models (syngeneic and humanized) to include method development and T-cell isolations for adoptive transfers. He regularly liaises with clients to provide PD study management, scientific discussion, data analysis and interpretation. Dr. Eberle independently has been supporting BD and strategic efforts for the Worcester discovery site.

Trained as biochemist, he specialized in cell-based assay development and validation across pre-clinical and clinical operations. In 2008, he received his PhD in Organic Chemistry from the University of Bremen (Germany). Dr. Eberle maintains a professional membership with the Institute of Clinical Research (ICR) in the United Kingdom and is also involved in the International Society for Advancement of Cytometry (ISAC). Prior to joining Charles River in 2017, he held scientific positions at Envigo, Eurofins Central Laboratory and the University Medical Center Göttingen (UMG) in Germany. Since 2013 he has been an Associate Fellow of the AACC Academy, formerly the National Academy of Clinical Biochemistry (NACB), and was elected Fellow of the Royal Society for Public Health (RSPH) in 2019. He also obtained a Lean Six Sigma Yellow Belt certification from Dartmouth Thayer School of Engineering.

LinkedIn Profile

Read Christoph's Publications

Articles

Featured Interviews

Featured Posters

Featured Webinars